Literature DB >> 2053780

[Syndrome of inappropriate antidiuretic hormone secretion following cisplatinum and vindesine administration in a patient with squamous cell carcinoma of the lung].

T Fukabori1, T Nakamura, T Kida, Y Fujita, T Goto, N Hiramori, T Fujii, Y Iwasaki, M Nakagawa.   

Abstract

We report a patient with squamous cell carcinoma of bronchus who developed the syndrome of inappropriate antidiuretic hormone secretion (SIADH) after receiving cisplatinum (CDDP) and vindesine (VDS). The 75-year-old man developed right chest pain and was found to have a squamous cell carcinoma of bronchus (stage IIIA, T3N1M0). He was treated by CDDP and VDS. The serum sodium concentration decreased from 136 mEq/l to 120 mEq/l after drug administration. SIADH was diagnosed on the basis of hyponatremia with corresponding serum hypoosmolality and an inappropriately high urinary osmolality due to continued sodium excretion. In our case, SI-ADH was probably induced by CDDP or VDS. Fluid restriction and sodium supplement resulted in a progressive rise in the serum sodium level to 134 mEq/l in 4 days.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2053780

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

Review 1.  Hyponatremia related to medical anticancer treatment.

Authors:  T Berghmans
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

2.  Cisplatin-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH) with life-threatening hyponatraemia.

Authors:  Aaron C Tan; Gavin M Marx
Journal:  BMJ Case Rep       Date:  2018-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.